scispace - formally typeset
W

WooJhon Choi

Researcher at Massachusetts Institute of Technology

Publications -  45
Citations -  2782

WooJhon Choi is an academic researcher from Massachusetts Institute of Technology. The author has contributed to research in topics: Optical coherence tomography & Blood flow. The author has an hindex of 22, co-authored 45 publications receiving 2398 citations. Previous affiliations of WooJhon Choi include Tufts Medical Center & KAIST.

Papers
More filters
Journal ArticleDOI

Quantitative OCT angiography of optic nerve head blood flow

TL;DR: OCT angiography can detect the abnormalities of ONH perfusion and has the potential to reveal the ONH blood flow mechanism related to glaucoma, a pilot study indicates.
Journal ArticleDOI

Choriocapillaris and Choroidal Microvasculature Imaging with Ultrahigh Speed OCT Angiography

TL;DR: The results demonstrate the feasibility of ultrahigh speed OCT for in vivo dye-free choriocapillaris and choroidal vasculature imaging, in addition to conventional structural imaging.
Journal ArticleDOI

Ultrahigh-Speed, Swept-Source Optical Coherence Tomography Angiography in Nonexudative Age-Related Macular Degeneration with Geographic Atrophy.

TL;DR: In this article, a volumetric optical coherence tomography angiography (OCTA) was used to noninvasively visualize alterations in the retinal and choriocapillaris (CC) vasculatures in normal subjects and patients with nonexudative age-related macular degeneration with geographic atrophy.
Journal ArticleDOI

Ultrahigh-speed swept-source OCT angiography in exudative AMD.

TL;DR: OCTA may offer noninvasive monitoring of the retinal and choriocapillaris microvasculature in patients with CNV, which may assist in diagnosis and monitoring.
Journal ArticleDOI

Handheld ultrahigh speed swept source optical coherence tomography instrument using a MEMS scanning mirror

TL;DR: An ultrahigh speed, handheld swept source optical coherence tomography (SS-OCT) ophthalmic instrument using a 2D MEMS mirror should enable screening applications to identify early retinal disease, before irreversible vision impairment or loss occurs.